ContraFect Corporation (CFRXQ)

ContraFect Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-24.14	-65.15	-20.28	-28.16	-12.79	-37.68
Depreciation & Amortization	0.16	0.15	0.15	0.17	0.17	0.15
Share-Based Compensation	3.42	3.87	3.19	2.58	1.45	1.56
Other Operating Activities	-15.03	15.15	-24.19	-7.78	-16.25	9.72
Operating Cash Flow	-35.59	-45.97	-41.13	-33.19	-27.43	-26.26
Capital Expenditures	-0.06	-0.06	0	0	-0.02	-0.13
Change in Investments	12.86	32.15	-11.61	-27.4	21.99	17.28
Investing Cash Flow	12.8	32.08	-11.61	-27.4	21.97	17.15
Share Issuance / Repurchase	26.56	7	57.61	55.53	23.03	11.51
Debt Issued / Paid	-0.79	0	0	0	0	0
Other Financing Activities	-2.24	-0.85	-3.7	-3.64	-1.71	-1.07
Financing Cash Flow	23.54	6.14	53.91	51.89	21.32	10.43
Net Cash Flow	0.75	-7.75	1.17	-8.7	15.86	1.33
Free Cash Flow	-35.65	-46.04	-41.13	-33.19	-27.45	-26.39
Free Cash Flow Per Share	-3.33	-88.30	-89.46	-116.63	-265.09	-277.58

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).